People · Operator
Named in public records as an officer, director or promoter · active 2018–2021 · Pharmaceuticals, Biotechnology, Retailing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ACON Injectable Investors I, L.P. | — | Pharmaceuticals | Series C | $59.0M | $1.5B | 2021 |
| ACON Bios Investors, L.P. | — | Biotechnology | Series B | $25.0M | $992.2M | 2018 |
| ACON Germaine Partners, L.P. | — | Retailing | Series A | $7.9M | $40.5M | 2019 |
Jose Knoell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jose Knoell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| TERESA Y. BERNSTEIN | 3 | 9 |
| KWAME Y. LEWIS | 2 | 4 |
| Kenneth Brotman | 1 | 7 |
| N/A ACON Bios GenPar, L.L.C. | 1 | 1 |
| N/A ALAOF V GenPar, L.L.C. | 1 | 1 |
| Masumi Y. Waida | 1 | 1 |
| Not Applicable ACON Germaine GP, L.L.C. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.